Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Liminal BioSciences Inc.
LMNL
Healthcare
Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed...
for trading on the Nasdaq Global Market.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:LMNL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(3)
•••
PLIImfoservice
X
View Profile
View Bullboard History
Comment by
PLIImfoservice
on Mar 16, 2022 11:23am
RE:RE:Patent update
Just checking to see if this stock is still alive
(529)
•••
Dibah420
X
View Profile
View Bullboard History
Comment by
Dibah420
on Mar 15, 2022 9:37am
RE:RE:Patent update
Divertissement gratuit ..
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(2)
•••
37minus4
X
View Profile
View Bullboard History
Comment by
37minus4
on Mar 15, 2022 9:19am
RE:Patent update
The return of the White Wine Barney Fife (skyhigh): good or bad omen? Discuss. ;-) 33
(3)
•••
PLIImfoservice
X
View Profile
View Bullboard History
Post by
PLIImfoservice
on Mar 15, 2022 4:06am
Patent update
Patents Assigned to LIMINAL BIOSCIENCES LIMITED Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
...more
(3)
•••
PLIImfoservice
X
View Profile
View Bullboard History
Post by
PLIImfoservice
on Mar 15, 2022 3:52am
Old news
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE LIMINAL BIOSCIENCES INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II)
...more
(199)
•••
PLITheOne
X
View Profile
View Bullboard History
Comment by
PLITheOne
on Mar 14, 2022 3:22pm
RE:RE:RE:"Nitrogen Scavenging Properties"
Thomvest had much more intel to the potential of Prometic and they wanted in and continued to invest for many years! WHY!? They'll never tell you or share any profits with peeon retail
...more
(199)
•••
PLITheOne
X
View Profile
View Bullboard History
Comment by
PLITheOne
on Mar 14, 2022 3:19pm
RE:RE:"Nitrogen Scavenging Properties"
Liminal's job is to make as much money and profit as they can for Thomvest, their owners, that’s business 101. If they need to misinform, misrepresent, and distort reality to accomplish
...more
(74)
•••
GunnerG
X
View Profile
View Bullboard History
Post by
GunnerG
on Mar 14, 2022 12:44pm
News? MAD and SAD is true.
Analysis of PK data from Phase 1 Multi-Ascending Dose ("MAD") clinical trial completed Data observed shows that fezagepras has nitrogen scavenging properties Planned
...more
(10)
•••
stockbuphoon
X
View Profile
View Bullboard History
Comment by
stockbuphoon
on Mar 14, 2022 10:00am
RE:"Nitrogen Scavenging Properties"
This study result was 100% telegraphed and expected that they would tank 4050 despite the early success in fibrosis on Alstrom and IPF. So, someone is lying. Was it previous management of Pierre
...more
(2)
•••
37minus4
X
View Profile
View Bullboard History
Post by
37minus4
on Mar 14, 2022 8:18am
"Nitrogen Scavenging Properties"
Well that is some thin gruel, boy. Maybe they can add some of their "scavenged nitrogen" to the poutine in the poutine shack. Tasty. ;-/ 33
(22)
•••
4Justice
X
View Profile
View Bullboard History
Comment by
4Justice
on Mar 12, 2022 7:07am
RE:YOU KNOW WHAT MAKES ME HAPPY
ZYMEWORKS did it. They hired Kenneth Galbraith as CEO in January ... and the stock price went from $15 US to $ 6,50. They are just seller of BS.
(77)
•••
crappot
X
View Profile
View Bullboard History
Post by
crappot
on Mar 10, 2022 10:51pm
Gota Go, set my beer traps.
...
(77)
•••
crappot
X
View Profile
View Bullboard History
Post by
crappot
on Mar 10, 2022 10:47pm
THEY ARE WATCHING THIS BOARD,
BUT NOT THEIR BACK. Take The Money and run, great song!
(77)
•••
crappot
X
View Profile
View Bullboard History
Post by
crappot
on Mar 10, 2022 10:36pm
YOU KNOW WHAT MAKES ME HAPPY
YOU A SS HOLES GOTA FIND A REAL JOB, Who the uck would hire Felons...
(77)
•••
crappot
X
View Profile
View Bullboard History
Post by
crappot
on Mar 10, 2022 8:25pm
AND I'M PISSED WITH 2g I gave to Quebecers...
JUST IMAGINE THE INVESTORS THAT GAVE YOU IDIOTS MORE...
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden